Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatments

7 Sept 2022

Abstract excerpt

Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) rapidly infects humans and animals which make coronavirus disease 2019 (COVID-19) a grievous epidemic worldwide which broke out in 2020. According to data analysis of the other coronavirus family, for instance severe acute respiratory syndrome SARS coronavirus (SARS-CoV), can provide experience for the mutation of SARS-CoV-2 and the prevention and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Influenza Virus Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36188605
DOI: 10.3389/fphar.2022.989664

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Toll-like receptor (TLRs) agonists and antagonists for COVID-19 treatmentsPMID 36188605Read ↗

TLRs: Innate Immune Sentries against SARS-CoV-2 InfectionSemantic proximity Read ↗

Interplay of TLR4 and SARS-CoV-2: Unveiling the Complex Mechanisms of Inflammation and Severity in COVID-19 InfectionsSemantic proximity Read ↗

Role of toll‐like receptors in modulation of cytokine storm signaling in SARS‐CoV‐2‐induced COVID‐19Semantic proximity Read ↗

Pattern Recognition Receptors Expression and Activation in COVID-19 and Long COVID: From SARS-CoV-2 Escape Mechanisms to Emerging ImmunotherapiesSemantic proximity Read ↗

TLR3 and TLR7 RNA Sensor Activation during SARS-CoV-2 InfectionSemantic proximity Read ↗

SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19Semantic proximity Read ↗

An Update on Toll-like Receptor 2, Its Function and Dimerization in Pro- and Anti-Inflammatory ProcessesSemantic proximity Read ↗

IMMUNE RESPONSE TO SARS CoV2 INFECTION BY TLR3, TLR4 AND TLR7 GENE EXPRESSIONSemantic proximity Read ↗

Toll-Like Receptors and Viruses: Induction of Innate Antiviral Immune ResponsesSemantic proximity Read ↗

SARS-CoV-2 mediated dysregulation in cell signaling events drives the severity of COVID-19Semantic proximity Read ↗

IMMUNE RESPONSE TO SARS CoV2 INFECTION BY TLR3, TLR4 AND TLR7 GENE EXPRESSION.Semantic proximity Read ↗

Toll-Like Receptor Signaling Pathways—Therapeutic OpportunitiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.